Rittenhouse Hematology/Oncology — Philadelphia, Pennsylvania

Rittenhouse Hematology/Oncology is a clinical research site located in Philadelphia, Pennsylvania, United States 19107.

Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.

Rittenhouse Hematology/Oncology has participated in 4 clinical trials with 1 currently active.

Therapeutic areas: Breast Cancer.

Sponsors: NSABP Foundation Inc, Celcuity Inc, Eli Lilly and Company.

Sponsor Feasibility Report

Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rittenhouse Hematology/Oncology?

Rittenhouse Hematology/Oncology has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rittenhouse Hematology/Oncology conducted?

Rittenhouse Hematology/Oncology has 4 clinical trials on record, with 1 currently active. Their work covers Breast Cancer.

Is Rittenhouse Hematology/Oncology accredited by Crixeo Health?

Rittenhouse Hematology/Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rittenhouse Hematology/Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.